These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1356571)

  • 1. Syndromes of chronic schizophrenia and some clinical correlates.
    Brown KW; White T
    Br J Psychiatry; 1992 Sep; 161():317-22. PubMed ID: 1356571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients.
    Brown KW; White T; Palmer D
    Psychol Med; 1992 Feb; 22(1):69-77. PubMed ID: 1349440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression measures and motor side-effects in patients with acute schizophrenia.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Margariti MM; Kollias CT; Christodoulou GN
    Schizophr Res; 2002 Jul; 56(1-2):197-8. PubMed ID: 12084435
    [No Abstract]   [Full Text] [Related]  

  • 4. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.
    Brown KW; White T
    Biol Psychiatry; 1991 Dec; 30(12):1182-90. PubMed ID: 1686411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of 15 patients with tardive dystonia.
    Sachdev P
    Am J Psychiatry; 1993 Mar; 150(3):498-500. PubMed ID: 8094600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.
    Gebhardt S; Härtling F; Hanke M; Theisen FM; von Georgi R; Grant P; Mittendorf M; Martin M; Fleischhaker C; Schulz E; Remschmidt H
    Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):44-53. PubMed ID: 17876506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation and treatment of neuroleptic-induced movement disorders.
    Gardos G; Cole JO
    Harv Rev Psychiatry; 1995; 3(3):130-9. PubMed ID: 9384940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
    Kim JH; Byun HJ
    Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review.
    Pappa S; Dazzan P
    Psychol Med; 2009 Jul; 39(7):1065-76. PubMed ID: 19000340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review.
    Halliday J; Farrington S; Macdonald S; MacEwan T; Sharkey V; McCreadie R
    Br J Psychiatry; 2002 Nov; 181():422-7. PubMed ID: 12411269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia.
    Halstead SM; Barnes TR; Speller JC
    Br J Psychiatry; 1994 Feb; 164(2):177-83. PubMed ID: 7909711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Handedness as a risk factor for neuroleptic-induced movement disorders.
    Brown KW; White T; Anderson F; McGilp R
    Biol Psychiatry; 1992 Apr; 31(7):746-8. PubMed ID: 1350923
    [No Abstract]   [Full Text] [Related]  

  • 15. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic restlessness with antipsychotics.
    Bratti IM; Kane JM; Marder SR
    Am J Psychiatry; 2007 Nov; 164(11):1648-54. PubMed ID: 17974927
    [No Abstract]   [Full Text] [Related]  

  • 17. The problem of tardive akathisia.
    Gualtieri CT
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias.
    Sachdev P
    Schizophr Bull; 1995; 21(3):451-61. PubMed ID: 7481575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Movement disorders in patients with schizophrenia and a history of substance abuse.
    Hansen LK; Nausheen B; Hart D; Kingdon D
    Hum Psychopharmacol; 2013 Mar; 28(2):192-7. PubMed ID: 23532750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.
    Gureje O
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1525-30. PubMed ID: 2906088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.